KY1005
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KY1005, covering 2023-01-27 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study [Phase 2]